Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...

Cardiovascular disease often culminates in heart failure, a hallmark of which is fibrosis, a form of tissue scarring. Cardiac fibrosis initially repairs damaged heart tissue, but it can quickly become ...

The article explores the role of the m 6 A reader YTHDF1 in cardiac fibrosis, a condition characterized by the excessive accumulation of extracellular matrix proteins, leading to the stiffening of the ...

Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to ...

Researchers have discovered that the same cellular mechanism involved in a form of cystic fibrosis is also implicated in a form of a rare disease called cystinosis. The mechanism cleans up mutated ...

Skin fibrosis is an often-painful condition wherein the skin thickens and hardens, making it difficult to move. And with no effective treatments currently available, patients are left with few avenues ...

Hepatic fibrosis arises from sustained liver injury of diverse aetiologies, including viral hepatitis, alcohol misuse and metabolic dysfunction. Central to its pathogenesis is the activation of ...

Dihydroartemisinin increases a chemical mark called H3K9ac on DNA in liver cells, opening the DNA to turn on the CHAC1 gene. This process is helped by a protein called ATF4, which activates CHAC1 ...

A single enzyme inside liver cells drives the production of triglycerides that, in excess, fuel the inflammation and scarring ...